Should a public company have to tell its shareholders that its CEO has been diagnosed with a potentially life-threatening illness? In the case of Steve Jobs, a CEO who is arguably Apple's single most valuable asset, I think the answer is "yes."
In the latest issue of Fortune, Peter Elkind dredges up some old news about Apple and Jobs--the backdating scandal, a 2003 bout with pancreatic cancer--but he also adds a new twist to the latter: Jobs and Apple's board knew...
]]>